Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
Pre-Market: 20:00
Utah Medical Products EPS Diluted (Quarterly) : 0.8436 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8436 |
| March 31, 2026 | 0.8176 |
| December 31, 2025 | 0.8024 |
| September 30, 2025 | 0.8204 |
| June 30, 2025 | 0.939 |
| March 31, 2025 | 0.9187 |
| December 31, 2024 | 0.8566 |
| September 30, 2024 | 1.024 |
| June 30, 2024 | 0.9776 |
| March 31, 2024 | 1.093 |
| December 31, 2023 | 1.181 |
| September 30, 2023 | 1.081 |
| June 30, 2023 | 1.154 |
| March 31, 2023 | 1.159 |
| December 31, 2022 | 1.253 |
| September 30, 2022 | 1.178 |
| June 30, 2022 | 1.124 |
| March 31, 2022 | 0.9643 |
| December 31, 2021 | 1.127 |
| September 30, 2021 | 1.150 |
| June 30, 2021 | 0.9374 |
| March 31, 2021 | 0.8274 |
| December 31, 2020 | 0.9343 |
| September 30, 2020 | 0.8029 |
| June 30, 2020 | 0.3588 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8432 |
| December 31, 2019 | 1.165 |
| September 30, 2019 | 0.9914 |
| June 30, 2019 | 0.9438 |
| March 31, 2019 | 0.8398 |
| December 31, 2018 | 0.9055 |
| September 30, 2018 | 1.802 |
| June 30, 2018 | 1.15 |
| March 31, 2018 | 1.09 |
| December 31, 2017 | -0.6778 |
| September 30, 2017 | 0.97 |
| June 30, 2017 | 1.04 |
| March 31, 2017 | 0.95 |
| December 31, 2016 | 0.725 |
| September 30, 2016 | 0.78 |
| June 30, 2016 | 0.86 |
| March 31, 2016 | 0.85 |
| December 31, 2015 | 0.852 |
| September 30, 2015 | 0.81 |
| June 30, 2015 | 0.77 |
| March 31, 2015 | 0.71 |
| December 31, 2014 | 0.796 |
| September 30, 2014 | 0.75 |
| June 30, 2014 | 0.75 |
| March 31, 2014 | 0.72 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.686M |
| Revenue (Quarterly) | 8.529M |
| Total Expenses (Quarterly) | 5.843M |
| Enterprise Value | 132.80M |
| Gross Profit Margin (Quarterly) | 55.60% |
| Profit Margin (Quarterly) | 31.49% |
| Earnings Yield | 4.75% |
| Operating Earnings Yield | 4.74% |
| Normalized Earnings Yield | 4.81 |